• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2020-2029  
Title Created Date
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma 28 February 2020
Anti-genotoxic and anti-mutagenic effects of melatonin supplementation in a mouse model of melanoma 28 February 2020
Melatonin in Mitochondria: Mitigating Clear and Present Dangers 27 February 2020
Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on 24 February 2020
Effect of Vitamin D Supplementation on Survival of Digestive Tract Cancer Patients with Low Bioavailable 25-Hydroxyvitamin D levels: A Post Hoc Analysis of the AMATERASU Randomized Clinical Trial 13 February 2020
Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis 12 February 2020
Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms 11 February 2020
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells 07 February 2020
Impact of dietary vitamin D on initiation and progression of oral cancer 07 February 2020
Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation 28 January 2020
Display # 

Page 80 of 81

  • Start
  • Prev
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • Next
  • End

Search

Follow us...

Latest

  • Growth hormone receptor promotes breast cancer progression via the BRAF/MEK/ERK signaling pathway
  • GH and IGF1 in cancer therapy resistance
  • Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice
  • About melatonin - 1996
  • Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
  • The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review
  • DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma
  • Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells
  • Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast Cancer
  • Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma
  • Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma
  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
  • Vitamin C as a Modulator of the Response to Cancer Therapy
  • An update on vitamin D signaling and cancer
  • AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone
  • All-Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Downregulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • How effective is chemo therapy?
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients